nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—XDH—uterine cervix—vaginal cancer	0.238	0.238	CbGeAlD
Deferoxamine—XDH—endometrium—vaginal cancer	0.215	0.215	CbGeAlD
Deferoxamine—XDH—mammalian vulva—vaginal cancer	0.208	0.208	CbGeAlD
Deferoxamine—XDH—female reproductive system—vaginal cancer	0.178	0.178	CbGeAlD
Deferoxamine—XDH—vagina—vaginal cancer	0.161	0.161	CbGeAlD
